195 related articles for article (PubMed ID: 35150338)
1. Effects of metformin on human bone-derived mesenchymal stromal cell-breast cancer cell line interactions.
Teufelsbauer M; Lang C; Plangger A; Rath B; Moser D; Staud C; Radtke C; Neumayer C; Hamilton G
Med Oncol; 2022 Feb; 39(5):54. PubMed ID: 35150338
[TBL] [Abstract][Full Text] [Related]
2. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
[TBL] [Abstract][Full Text] [Related]
3. N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells.
Choi S; Yu J; Kim W; Park KS
Theranostics; 2021; 11(14):6786-6799. PubMed ID: 34093853
[No Abstract] [Full Text] [Related]
4. Effects of metformin on adipose-derived stromal cell (ADSC) - Breast cancer cell lines interaction.
Teufelsbauer M; Rath B; Plangger A; Staud C; Nanobashvili J; Huk I; Neumayer C; Hamilton G; Radtke C
Life Sci; 2020 Nov; 261():118371. PubMed ID: 32882267
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors.
Zhang T; Lee YW; Rui YF; Cheng TY; Jiang XH; Li G
Stem Cell Res Ther; 2013 Jun; 4(3):70. PubMed ID: 23763837
[TBL] [Abstract][Full Text] [Related]
6. Two Novel Tri-Aryl Derivatives Attenuate the Invasion-Promoting Effects of Stromal Mesenchymal Stem Cells on Breast Cancer.
Moradi K; Barneh F; Irian S; Amini M; Moradpoor R; Amanzadeh A; Choopani S; Rahimi H; Ghodselahi T; Boujar MM; Salimi M
Anticancer Agents Med Chem; 2019; 19(8):1002-1011. PubMed ID: 30747082
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
[TBL] [Abstract][Full Text] [Related]
8. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.
Shin HS; Sun HJ; Whang YM; Park YJ; Park DJ; Cho SW
Thyroid; 2021 May; 31(5):760-771. PubMed ID: 32791889
[No Abstract] [Full Text] [Related]
9. Interactions of BRCA1-mutated Breast Cancer Cell Lines with Adipose-derived Stromal Cells (ADSCs).
Plangger A; Haslik W; Rath B; Neumayer C; Hamilton G
J Mammary Gland Biol Neoplasia; 2021 Sep; 26(3):235-245. PubMed ID: 34228231
[TBL] [Abstract][Full Text] [Related]
10. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
[TBL] [Abstract][Full Text] [Related]
11. Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells.
Kucerova L; Skolekova S; Matuskova M; Bohac M; Kozovska Z
BMC Cancer; 2013 Nov; 13():535. PubMed ID: 24209831
[TBL] [Abstract][Full Text] [Related]
12. BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells.
Wan S; Liu Y; Weng Y; Wang W; Ren W; Fei C; Chen Y; Zhang Z; Wang T; Wang J; Jiang Y; Zhou L; He T; Zhang Y
Cell Oncol (Dordr); 2014 Oct; 37(5):363-75. PubMed ID: 25209393
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells.
Pelagalli A; Nardelli A; Fontanella R; Zannetti A
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27409610
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone-treated mouse mesenchymal stem cells-derived conditioned medium inhibits human breast cancer cells in vitro.
Hajmomeni P; Sisakhtnezhad S; Bidmeshkipour A
Chem Biol Interact; 2023 Jan; 369():110283. PubMed ID: 36450322
[TBL] [Abstract][Full Text] [Related]
16. Tumor Microenvironment Changing through Application of MicroRNA-34a Related Mesenchymal Stem Cells Conditioned Medium: Modulation of Breast Cancer Cells toward Non-aggressive Behavior.
Bahman Soufiani K; Pourfathollah AA; Nikougoftar Zarif M; Arefian E
Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):221-232. PubMed ID: 33904680
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of cancer cells' secreted factors on human stromal (mesenchymal) stem cells.
Al-toub M; Almusa A; Almajed M; Al-Nbaheen M; Kassem M; Aldahmash A; Alajez NM
Stem Cell Res Ther; 2013 Sep; 4(5):114. PubMed ID: 24405819
[TBL] [Abstract][Full Text] [Related]
18. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
Pietrovito L; Leo A; Gori V; Lulli M; Parri M; Becherucci V; Piccini L; Bambi F; Taddei ML; Chiarugi P
Mol Oncol; 2018 May; 12(5):659-676. PubMed ID: 29517849
[TBL] [Abstract][Full Text] [Related]
20. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
